Ons Bio LLC
Brunswick, OH
- UEI
- TQV5KBDJBC58
- CAGE
- 8CDB6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Sole Proprietorship
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2800 Center Rd, Brunswick, OH 44212, USA
- Website
- onsbio.com
- Founded
- 2019
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Service: custom peptide synthesis. Estimate 1146. | Office of Logisitics and Acquisition Operations | $25,907 | |
| Peptide synthesis | National Human Genome Research Institute | $14,706 | |
| 3D bioprinter with post-warranty preventive maintenance and repair service | Food and Drug Administration | $99,835 |
About Ons Bio LLC
Ons Bio LLC, a Brunswick, Ohio–based sole proprietorship, supplies custom peptide synthesis and 3D bioprinting equipment with maintenance services to the National Institutes of Health and the Food and Drug Administration as a small-business prime contractor on purchase orders, with no subcontract footprint.
Ons Bio operates exclusively in the full-and-open competitive space, holding no SBA set-aside designations across its federal award portfolio; the sole small-business set-aside in the source data—the FDA's 3D bioprinter procurement in 2021—was designated total small business by the customer agency rather than pursued under a specific SBA category. The vendor's capability portfolio centers on peptide synthesis and bioprinting equipment provision. Representative work includes a $162,835 firm fixed price purchase order from FDA's Center for Drug Evaluation and Research for a 3D bioprinter with post-warranty preventive maintenance and repair service (awarded August 2, 2021, ultimate completion October 1, 2026), a $14,706.15 peptide synthesis purchase order from the National Human Genome Research Institute awarded July 1, 2024, and a $25,907.40 custom peptide synthesis purchase order from the same institute awarded June 15, 2026 with completion targeted for June 14, 2027.
Customer concentration is polarized by dollar value. The FDA accounts for $163 thousand of the combined potential value across three awards (80%), while the National Human Genome Research Institute carries two awards totaling $41 thousand (20%). Activity is sparse—one award in 2021, one in 2024, one in 2026—with $203 thousand in combined potential value across all three federal contracts. Two awards (combined potential value $189 thousand) face ultimate completion within the next twenty-four months, presenting recompete opportunity in that window. Ons Bio obligated $140 thousand (69% of combined potential value) across the portfolio as of the source snapshot.
Quick answers
What is Ons Bio LLC's UEI?
Ons Bio LLC's Unique Entity ID (UEI) in SAM.gov is TQV5KBDJBC58.
What is Ons Bio LLC's CAGE code?
Ons Bio LLC's CAGE code is 8CDB6.
What is Ons Bio LLC's primary NAICS code?
Ons Bio LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Ons Bio LLC located?
Ons Bio LLC's physical address in SAM.gov is 2800 Center Rd, Brunswick, OH 44212, USA.
Is Ons Bio LLC registered in SAM.gov?
Yes. Ons Bio LLC's SAM.gov registration is active through August 17, 2027.
What is Ons Bio LLC's most recent federal award?
Ons Bio LLC's most recent federal contract award is Service: custom peptide synthesis. Estimate 1146 (75N98026P00788), from Office of Logisitics and Acquisition Operations, on June 15, 2026.
On GovTribe
See Ons Bio LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors